Archive for 2013

Data on the Selexis SUREtechnology Platform to be Presented at PEPTALK…

Next Generation Cell Lines for Overcoming Expression Bottlenecks – Bispecific Antibodies from a Novel Stable Expression Platform(PRWeb January 16, 2013)Read the full story at…

CIS MDI (Methyl Diphenyl Diisocyanate) Market – New Industry Research…

According to a new market report published by Transparency Market Research “CIS (Russia, Ukraine, Others) MDI (Methyl Diphenyl Diisocyanate) Market – Industry Analysis, Raw Material, Consumption…

(PRWeb January 16, 2013)

Read the full story at

LATISTA Announces Next-Generation iPad App 2.0 for Construction with…

LATISTA announces the release of the new LATISTA for iPad 2.0, now available on the Apple iTunes Store. The new release includes innovations such as visual punch list, interactive inspection forms and…(PRWeb January 16, 2013)Read the full story at…

Rigaku Publishes Application Note for Accurate Quantitative Analysis…

Rigaku Corporation has published of a new application report describing accurate ferrosilicon analysis using the Rigaku ZSX Primus III+ WDXRF spectrometer.(PRWeb January 16, 2013)Read the full story at…

Wysebridge Patent Bar Review Announces the Launch of News Blog

Wysebridge Launches Free News Blog to Help Individuals Leaning about Patents and The Patent Bar Exam.(PRWeb January 16, 2013)Read the full story at

Chemical Publishing Company Seeking Authors for Titles on Waste Water…

Potential authors, corporations and universities that wish to publish materials on the subject of water and waste water treatment are encouraged to submit full or partial manuscripts to Chemical…(PRWeb January 16, 2013)Read the full story at http:…

GlycoCheck Announces Partnership in the United States with Vascular…

Vascular Health Sciences is announced as the exclusive provider of new artery health technology in the United States.(PRWeb January 16, 2013)Read the full story at

Convoy Therapeutics Announces the Relaunch of Their Interactive…

Convoy Therapeutics has relaunched their website to include interactive information about their innovative technologies in skin-penetrating treatments. The website contains detailed backgrounds on…(PRWeb January 16, 2013)Read the full story at ht…

Drug Patent Expirations for Jan 2 2013

If your reader cannot render the information below, go to to see the latest expirations


This newsletter is a
free service of DrugPatentWatch

DrugPatentWatch offers comprehensive details on FDA approved drugs,
developers, and their patents

Simple flat-rate database subscription

Ultimate Plan Premium
Basic Plan
One year $1,995 Subscribe $1,795 Subscribe $1,095 Subscribe
One month $525 Subscribe $425 Subscribe $325 Subscribe
48 hours $95 Subscribe $75 Subscribe

Drug Patent Expirations for January 2 2013

Tradename Applicant Generic Name Patent
LUPRON DEPOT Abbott Endocrine leuprolide acetate Jan 2, 2013
LUPRON DEPOT-PED Abbott Endocrine leuprolide acetate Jan 2, 2013

*Drugs may be
covered by multiple patents or regulatory protections. See the DrugPatentWatch
database for complete details.

DrugPatentWatch Serves Your Competitive Intelligence

Subscribers have
access to valuable datasets, including:
  • Patent litigation
  • Clinical trial information
  • International patent families
  • International patent priority and PCT
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Drug Master Files
  • Dynamic search capabilities with data
  • More…
See the Database
and Plan
. Contact Us with any

The above list
does not discriminate between dominant and non-dominant patents. Drugs
listed above may be protected by additional patents and other regulatory
protections. See the DrugPatentWatch
database for complete details

Although great care is taken in the proper and correct provision of this
service, thinkBiotech LLC does not accept any responsibility for possible
consequences of errors or omissions in the provided information. There is
no warranty that the information contained herein is error free. Users of
this service are advised to seek professional advice and independent
confirmation before acting on any of the provided information. thinkBiotech
LLC reserves the right to amend, extend or withdraw any part or all of the
offered service without notice.
All trademarks and applicant names
are the property of their respective owners or